ILLUMINA, INC. — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
Illumina reported Q2 2026 revenue of $1.159B (+9.5% YoY, +8.1% organic ex-China), with GAAP operating margin 21.1% and non-GAAP 22.5%. The company raised FY2026 total revenue guidance to $4.60–$4.64B (prior: $4.52–$4.62B) and non-GAAP diluted EPS to $5.30–$5.40 (prior: $5.15–$5.30), while maintaining non-GAAP operating margin guidance of 23.4–23.6%. ROW organic growth guidance increased to >5% from 2–4%.
Why this rating
Guidance raise and organic growth acceleration are solid, but Q2 net income declined 12% YoY ($207M vs. $235M) and free cash flow fell 21% YoY ($162M vs. $204M). Incremental guidance adjustment ~$90M revenue (2% of $4.6B midpoint) modest relative to $9.2B market cap; execution risk on SomaLogic integration and China headwinds remain.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.